Home / Recalls / Denver Solutions, LLC DBA Leiters Health / D-0444-2023

D-0444-2023 Class II Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

Recall Details

Product Type: Drugs
Report Date: March 15, 2023
Initiation Date: February 21, 2023
Termination Date: January 11, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1212 units

Product Description

Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-150-82

Reason for Recall

CGMP DEVIATIONS

Distribution Pattern

Nationwide within the United States including VA or other Government facilities

Code Information

Lot #: 2231017, Exp. Date 3/12/2023

Other recalls by Denver Solutions, LLC DBA Leiters Health

D-0374-2025 Class II — Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx onl (March 31, 2025)
D-0371-2025 Class II — dexmedeTOMIDine HCl PF, in 0.9% Sodium Chloride, 20 mcg (base) per 5mL, (4 mcg ( (March 31, 2025)
D-0372-2025 Class II — PHENYLephrine HCl in 0.9% Sodium Chloride, 0.5 mg per 5mL (100 mcg/mL), 5 mL Sin (March 31, 2025)
D-0370-2025 Class II — Glycopyrrolate, 1mg per 5mL, (0.2 mg/mL), Single Dose 5 mL syringe, Rx only, Lei (March 31, 2025)
D-0373-2025 Class II — Ketamine HCl 50mg per 5mL (10 mg per mL), 5mL Single Dose Syringe, Rx only, Lei (March 31, 2025)
D-0361-2024 Class II — Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injecti (February 20, 2024)
D-0363-2024 Class II — Lidocaine HCL 1% (10mg/mL), PHENYLephrine HCL 1.5% (15mg/mL), 1 ml in a Single- (February 20, 2024)
D-0362-2024 Class II — Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark (February 20, 2024)
D-0278-2024 Class I — FentaNYL citrate PF, 2500 mcg per 250 mL 0.9% Sodium Chloride (10 mcg per mL), I (December 28, 2023)
D-0282-2024 Class I — VANCOmycin HCl PF 1.5g added to 0.9% Sodium Chloride 250 mL IV bag, Item F3208, (December 28, 2023)